Want to see IOBTQ full AI Analyst Report?
IO Biotech (IOBTQ) Financial Statements
IO Biotech Financial Overview
IO Biotech's market cap is currently $7.20K. The company's EPS TTM is $-1.35; its P/E ratio is -0.01; IO Biotech has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 24 | Dec 23 | Dec 22 | Mar 22 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -849.00K | $ -756.00K | $ -540.00K | $ 0.00 | $ 0.00 |
| Operating Income | $ -95.18M | $ -91.44M | $ -71.42M | $ -41.23M | $ -10.14M |
| EBITDA | $ -93.20M | $ -84.47M | $ -69.34M | $ -67.45M | $ -12.02M |
| Net Income | $ -95.49M | $ -86.08M | $ -71.46M | $ -67.88M | $ -12.04M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 60.03M | $ 143.19M | $ 142.59M | $ 211.53M | $ 3.40M |
| Total Assets | $ 67.70M | $ 150.72M | $ 151.81M | $ 222.29M | $ 5.65M |
| Total Debt | $ 1.92M | $ 2.49M | $ 2.79M | $ 0.00 | $ 0.00 |
| Net Debt | $ -58.12M | $ -140.70M | $ -139.80M | $ -211.53M | $ -3.40M |
| Total Liabilities | $ 20.68M | $ 17.56M | $ 12.95M | $ 10.36M | $ 3.05M |
| Stockholders' Equity | $ 47.02M | $ 133.16M | $ 138.85M | $ 211.92M | $ 2.60M |
| Cash Flow | |||||
| Free Cash Flow | $ -82.39M | $ -72.06M | $ -60.42M | $ -40.80M | $ -9.96M |
| Operating Cash Flow | $ -82.35M | $ -71.74M | $ -59.73M | $ -40.65M | $ -9.96M |
| Investing Cash Flow | $ -44.00K | $ -323.00K | $ -690.00K | $ -153.00K | $ 0.00 |
| Financing Cash Flow | $ 0.00 | $ 71.86M | $ 0.00 | $ 252.95M | $ 5.10M |
Currency in USD
